SIK2 and ovarian cancer: Adipocytes activate SIK2 via the phospholipase/Ca2+ transduction pathway, which augments PI3K-Akt signaling and acetyl-CoA carboxylases (ACC) phosphorylation in ovarian cancer cells (33).